The pharma company had to scale vaccine production from 200 million annually to 3 billion at the pandemic's peak.
In 2025's third quarter, multiple large vaccine developers, including Pfizer and GSK, saw vaccine sales tick up globally ...
10d
Pfizer CEO Calls RFK's Vaccine Views Anti-Science, Warns US Falling Behind China In Health Research
Pfizer CEO Albert Bourla criticizes RFK's vaccine stance, warns US health research is losing ground to China, and urges ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results